New covalent and non-covalent SARS-CoV-2 inhibitors discovered in silico 03/28/2021 Health News, With the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute...
SARS-CoV-2's amyloid-driving nucleoprotein could inform future therapeutic research 03/09/2021 Health News, Amyloids are commonly associated with misfolded proteins that increase the risk of developing Alzheimer’s disease....
Robotically precise diagnostics and therapeutics for degenerative disc disorder 10/30/2020 Health News, Lower back pain caused by degenerative disc disorder affects approximately 40% of the population over...
Dengue virus becoming resistant to vaccines and therapeutics due to mutations in specific protein 09/20/2019 Medications, Researchers from Duke-NUS Medical School (Duke-NUS), in collaboration with the Agency for Science, Technology and...
G1 Therapeutics Presents Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin for Treatment of First-Line Small Cell Lung Cancer 10/23/2018 Medications, RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX),...
Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease 09/15/2018 Medications, CRANBURY, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology...